Brief: Advaxis Announces Receipt Of Funding Milestone Payment Under ADXS-Her2 Licensing Agreement With OS Therapies
19/01/2021 14:12
Jan 19 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES RECEIPT OF FUNDING MILESTONE PAYMENT
UNDER
ADXS-HER2 LICENSING AGREEMENT WITH OS THERAPIES
Source text for Eikon: ID:nGNX3rfBFD
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors